Cross-sex hormone therapy for gender dysphoria

被引:21
作者
Fabris, B. [1 ]
Bernardi, S. [1 ]
Trombetta, C. [2 ]
机构
[1] Univ Trieste, Dept Med Surg & Hlth Sci, Div Internal Med, Trieste, Italy
[2] Univ Trieste, Dept Med Surg & Hlth Sci, Div Urol, Trieste, Italy
关键词
Gender dysphoria; Transsexualism; Cross-sex hormone therapy; Estrogens; Anti-androgens; Testosterone; TO-MALE TRANSSEXUALS; TESTOSTERONE REPLACEMENT THERAPY; POLYCYSTIC-OVARY-SYNDROME; TERM-FOLLOW-UP; ENDOCRINE TREATMENT; ANDROGEN TREATMENT; BREAST-CANCER; FEMALE TRANSSEXUALS; RECEIVING TREATMENT; IDENTITY DISORDER;
D O I
10.1007/s40618-014-0186-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Gender identity is the sense one has of being male or female. Gender dysphoria (GD) refers to the distress caused by the incongruence between gender identity and biological sex in gender-nonconforming individuals. Cross-sex hormone therapy (CHT) aims at easing GD, improving well-being, and quality of life of gender-nonconforming individuals. This can be achieved by inducing and maintaining the desired-sex characteristics in accordance with the specific aspirations and expectations of each individual. Nevertheless, CHT can be associated with potentially serious long-term complications. Methods Here, we review when, how, and how long to prescribe CHT to adult transsexuals as well as what to expect and monitor once it has been initiated. Results In recent years, transsexualism has become more and more recognized and depathologized. To manage GD, National and International Standards of Care have been established. Nevertheless, the needs of transgender patients can still be ignored or dismissed. Moreover, some questions remain unanswered because of the lack of specific retrospective or prospective studies on CHT. Conclusion Education and culturally sensitive training must be supplied to healthcare professionals to overcome the existing issues on GD management and change the perspectives of transsexual people.
引用
收藏
页码:269 / 282
页数:14
相关论文
共 50 条
  • [41] Cross-sex hormonal replacement: Some effects over mitochondria
    Cardenas, Montserrat
    Alvarez, Fabian
    Cabrera-Orefice, Alfredo
    Paredes-Carbajal, Cristina
    Silva-Palacios, Alejandro
    Uribe-Carvajal, Salvador
    Garcia-Trejo, Jose J.
    Pavon, Natalia
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 244
  • [42] Cross sex hormone treatment is linked with a reversal of cerebral patterns associated with gender dysphoria to the baseline of cisgender controls
    Kilpatrick, Lisa A.
    Holmberg, Mats
    Manzouri, Amirhosein
    Savic, Ivanka
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 50 (08) : 3269 - 3281
  • [43] Gender dysphoria: the endocrinologist role
    Weill, Catherine Bremont
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2017, 21 (07): : 140 - 150
  • [44] Alterations in Body Uneasiness, Eating Attitudes, and Psychopathology Before and After Cross-Sex Hormonal Treatment in Patients with Female-to-Male Gender Dysphoria
    Şenol Turan
    Cana Aksoy Poyraz
    Nazife Gamze Usta Sağlam
    Ömer Faruk Demirel
    Özlem Haliloğlu
    Pınar Kadıoğlu
    Alaattin Duran
    Archives of Sexual Behavior, 2018, 47 : 2349 - 2361
  • [45] (Patho)physiology of cross-sex hormone administration to transsexual people: the potential impact of male-female genetic differences
    Gooren, L. J.
    Kreukels, B.
    Lapauw, B.
    Giltay, E. J.
    ANDROLOGIA, 2015, 47 (01) : 5 - 19
  • [46] Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review
    Kotamarti, Vasanth S.
    Greige, Nicolas
    Heiman, Adee J.
    Patel, Ashit
    Ricci, Joseph A.
    JOURNAL OF SEXUAL MEDICINE, 2021, 18 (07) : 1280 - 1291
  • [47] Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone Agonist
    Mueller, A.
    Zollver, H.
    Kronawitter, D.
    Oppelt, P. G.
    Claassen, T.
    Hoffmann, I.
    Beckmann, M. W.
    Dittrich, R.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (02) : 95 - 100
  • [48] Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study
    de Blok, Christel Josefa Maria
    Klaver, Maartje
    Wiepjes, Chantal Maria
    Nota, Nienke Marije
    Heijboer, Annemieke Corine
    Fisher, Alessandra Daphne
    Schreiner, Thomas
    T'Sjoen, Guy
    den Heijer, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02) : 532 - 538
  • [49] Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment
    Gooren, Louis J.
    van Trotsenburg, Michael A. A.
    Giltay, Erik J.
    van Diest, Paul J.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 (12) : 3129 - 3134
  • [50] The stability of autistic traits in transgender adults following cross-sex hormone treatment
    Nobili, Anna
    Glazebrook, Cris
    Bouman, Walter Pierre
    Baron-Cohen, Simon
    Arcelus, Jon
    INTERNATIONAL JOURNAL OF TRANSGENDER HEALTH, 2020, 21 (04) : 431 - 439